United States Urokinase Market by Manufacturers, States, Type and Application, Forecast to 2022

United States Urokinase Market by Manufacturers, States, Type and Application, Forecast to 2022

Published by: GIR (Global Info Research)
Catalog: Pharmaceuticals
Publishing Date:  Nov 2017
Single User License: USD 4480
Corporate Users License: USD 8960
Delivery time: 48 hours
Pages: 124
Tables and Figures: 139
Contact: Tel: 00852-58197708 (HK); Email: sales@globalinforesearch.com

Description
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.


Scope of the Report:
This report focuses on the Urokinase in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers
    NDPharm
    Wanhua Biochem
    Jiangxi Haoran Bio-Pharma
    Jiangsu Aidea Pharmaceutical

Market Segment by States, covering
    California
    Texas
    New York
    Florida
    Illinois

Market Segment by Type, covers
    Urokinase Powder
    Urokinase Solution

Market Segment by Applications, can be divided into
    Hospital
    Clinic
    Others

There are 17 Chapters to deeply display the United States Urokinase market.

Chapter 1, to describe Urokinase Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Urokinase, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Urokinase, for each state, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue,   market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Urokinase market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers etc.

Chapter 16 and 17, to describe Urokinase Research Findings and Conclusion, Appendix, methodology and data source.


Table of Contents
1 Market Overview
    1.1 Urokinase Introduction
    1.2 Market Analysis by Type
        1.2.1 Urokinase Powder
        1.2.2 Urokinase Solution
    1.3 Market Analysis by Applications
        1.3.1 Hospital
        1.3.2 Clinic
        1.3.3 Others
    1.4 Market Analysis by States
        1.4.1 California Status and Prospect (2012-2022)
        1.4.2 Texas Status and Prospect (2012-2022)
        1.4.3 New York Status and Prospect (2012-2022)
        1.4.4 Florida Status and Prospect (2012-2022)
        1.4.5 Illinois Status and Prospect (2012-2022)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 NDPharm
        2.1.1 Profile
        2.1.2 Urokinase Type and Applications
            2.1.2.1 Type 1
            2.1.2.2 Type 2
        2.1.3 NDPharm Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.1.4 Business Overview
        2.1.5 NDPharm News
    2.2 Wanhua Biochem
        2.2.1 Profile
        2.2.2 Urokinase Type and Applications
            2.2.2.1 Type 1
            2.2.2.2 Type 2
        2.2.3 Wanhua Biochem Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.2.4 Business Overview
        2.2.5 Wanhua Biochem News
    2.3 Jiangxi Haoran Bio-Pharma
        2.3.1 Profile
        2.3.2 Urokinase Type and Applications
            2.3.2.1 Type 1
            2.3.2.2 Type 2
        2.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.3.4 Business Overview
        2.3.5 Jiangxi Haoran Bio-Pharma News
    2.4 Jiangsu Aidea Pharmaceutical
        2.4.1 Profile
        2.4.2 Urokinase Type and Applications
            2.4.2.1 Type 1
            2.4.2.2 Type 2
        2.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        2.4.4 Business Overview
        2.4.5 Jiangsu Aidea Pharmaceutical News
3 United States Urokinase Market Competition, by Manufacturer
    3.1 United States Urokinase Sales and Market Share by Manufacturer (2016-2017)
    3.2 United States Urokinase Revenue and Market Share by Manufacturer (2016-2017)
    3.3 United States Urokinase Price by Manufacturers (2016-2017)
    3.4 Market Concentration Rate
        3.4.1 Top 3 Urokinase Manufacturer Market Share
        3.4.2 Top 5 Urokinase Manufacturer Market Share
    3.5 Market Competition Trend
4 United States Urokinase Market Analysis by States
    4.1 United States Urokinase Sales Market Share by States
    4.2 United States Urokinase Sales by States (2012-2017)
    4.3 United States Urokinase Revenue (Value) by States (2012-2017)
5 United States Market Segmentation Urokinase by Type
    5.1 United States Urokinase Sales, Revenue and Market Share by Type (2012-2017)
        5.1.1 United States Urokinase Sales and Market Share by Type (2012-2017)
        5.1.2 United States Urokinase Revenue and Market Share by Type (2012-2017)
    5.2 Urokinase Powder Sales Growth and Price
        5.2.1 United States Urokinase Powder Sales Growth (2012-2017)
        5.2.2 United States Urokinase Powder Price (2012-2017)
    5.3 Urokinase Solution Sales Growth and Price
        5.3.1 United States Urokinase Solution Sales Growth (2012-2017)
        5.3.2 United States Urokinase Solution Price (2012-2017)
6 United States Market Segmentation Urokinase by Application
    6.1 United States Urokinase Sales Market Share by Application (2012-2017)
    6.2 Hospital Sales Growth (2012-2017)
    6.3 Clinic Sales Growth (2012-2017)
    6.4 Others Sales Growth (2012-2017)
7 California Urokinase Sales, Revenue, by Type, Application and Manufacturers
    7.1 California Urokinase Revenue, Sales and Growth Rate (2012-2017)
    7.2 California Urokinase Sales and Market Share by Type
    7.3 California Urokinase Sales by Application (2012-2017)
8 New York Urokinase Sales, Revenue, by Type, Application and Manufacturers
    8.1 New York Urokinase Revenue, Sales and Growth Rate (2012-2017)
    8.2 New York Urokinase Sales and Market Share by Type
    8.3 New York Urokinase Sales by Application (2012-2017)
9 Texas Urokinase Sales, Revenue, by Type, Application and Manufacturers
    9.1 Texas Urokinase Revenue, Sales and Growth Rate (2012-2017)
    9.2 Texas Urokinase Sales and Market Share by Type
    9.3 Texas Urokinase Sales by Application (2012-2017)
10 Florida Urokinase Sales, Revenue, by Type, Application and Manufacturers
    10.1 Florida Urokinase Revenue, Sales and Growth Rate (2012-2017)
    10.2 Florida Urokinase Sales and Market Share by Type
    10.3 Florida Urokinase Sales by Application (2012-2017)
11 Illinois Urokinase Sales, Revenue, by Type, Application and Manufacturers
    11.1 Illinois Urokinase Revenue, Sales and Growth Rate (2012-2017)
    11.2 Illinois Urokinase Sales and Market Share by Type
    11.3 Illinois Urokinase Sales by Application (2012-2017)
12 Urokinase Market Forecast (2017-2022)
    12.1 United States Urokinase Sales, Revenue and Growth Rate (2017-2022)
    12.2 Urokinase Market Forecast by States (2017-2022)
    12.3 Urokinase Market Forecast by Type (2017-2022)
    12.4 Urokinase Market Forecast by Application (2017-2022)
13 Urokinase Manufacturing Cost Analysis
    13.1 Urokinase Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Price Trend of Key Raw Materials
        13.1.3 Key Suppliers of Raw Materials
        13.1.4 Market Concentration Rate of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
        13.2.1 Raw Materials
        13.2.2 Labor Cost
        13.2.3 Manufacturing Expenses
    13.3 Manufacturing Process Analysis of Urokinase
14 Industrial Chain, Sourcing Strategy and Downstream Buyers
    14.1 Urokinase Industrial Chain Analysis
    14.2 Upstream Raw Materials Sourcing
    14.3 Raw Materials Sources of Urokinase Major Manufacturers in 2016
    14.4 Downstream Buyers
15 Sales Channel, Distributors, Traders and Dealers
    15.1 Sales Channel
        15.1.1 Direct Marketing
        15.1.2 Indirect Marketing
        15.1.3 Marketing Channel Future Trend
    15.2 Distributors, Traders and Dealers
16 Research Findings and Conclusion
17 Appendix
    17.1 Methodology
    17.2 Analyst Introduction
    17.3 Data Source


List of Tables and Figures

Figure Urokinase Picture
Table Product Specifications of Urokinase
Figure United States Sales Market Share of Urokinase by Types in 2016
Table Types of Urokinase
Figure Urokinase Powder Picture
Table Major Manufacturers of Urokinase Powder
Figure Urokinase Solution Picture
Table Major Manufacturers of Urokinase Solution
Table United States Urokinase Sales Market Share by Applications in 2016
Table Applications of Urokinase
Figure Hospital Picture
Figure Clinic Picture
Figure Others Picture
Figure California Urokinase Revenue (Million USD) and Growth Rate (2012-2022)
Figure Texas Urokinase Revenue (Million USD) and Growth Rate (2012-2022)
Figure New York Urokinase Revenue (Million USD) and Growth Rate (2012-2022)
Figure Florida Urokinase Revenue (Million USD) and Growth Rate (2012-2022)
Figure Illinois Urokinase Revenue (Million USD) and Growth Rate (2012-2022)
Table NDPharm Basic Information, Manufacturing Base and Competitors
Table NDPharm Urokinase Type and Applications
Table NDPharm Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Wanhua Biochem Basic Information, Manufacturing Base and Competitors
Table Wanhua Biochem Urokinase Type and Applications
Table Wanhua Biochem Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jiangxi Haoran Bio-Pharma Basic Information, Manufacturing Base and Competitors
Table Jiangxi Haoran Bio-Pharma Urokinase Type and Applications
Table Jiangxi Haoran Bio-Pharma Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jiangsu Aidea Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Jiangsu Aidea Pharmaceutical Urokinase Type and Applications
Table Jiangsu Aidea Pharmaceutical Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Urokinase Sales by Manufacturer (2016-2017)
Figure United States Urokinase Sales Market Share by Manufacturer in 2016
Figure United States Urokinase Sales Market Share by Manufacturer in 2017
Table United States Urokinase Revenue by Manufacturer (2016-2017)
Figure United States Urokinase Revenue Market Share by Manufacturer in 2015
Figure United States Urokinase Revenue Market Share by Manufacturer in 2016
Table United States Urokinase Price by Manufacturers (2016-2017)
Figure Top 3 Urokinase Manufacturer Market Share in 2016
Figure Top 3 Urokinase Manufacturer Market Share in 2017
Figure Top 5 Urokinase Manufacturer Market Share in 2016
Figure Top 5 Urokinase Manufacturer Market Share in 2017
Figure United States Urokinase Sales and Growth (2012-2017)
Table United States Urokinase Sales by States (2012-2017)
Table United States Urokinase Sales Market Share by States (2012-2017)
Figure United States 2012 Urokinase Sales Market Share by States
Figure United States 2016 Urokinase Sales Market Share by States
Figure United States Urokinase Revenue and Growth (2012-2017)
Table United States Urokinase Revenue by States (2012-2017)
Table United States Urokinase Revenue Market Share by States (2012-2017)
Table United States 2012 Urokinase Revenue Market Share by States
Table United States 2016 Urokinase Revenue Market Share by States
Table United States Urokinase Sales by Type (2012-2017)
Table United States Urokinase Sales Share by Type (2012-2017)
Table United States Urokinase Revenue by Type (2012-2017)
Table United States Urokinase Revenue Share by Type (2012-2017)
Figure United States Urokinase Powder Sales Growth (2012-2017)
Figure United States Urokinase Powder Price (2012-2017)
Figure United States Urokinase Solution Sales Growth (2012-2017)
Figure United States Urokinase Solution Price (2012-2017)
Table United States Urokinase Sales by Application (2012-2017)
Table United States Urokinase Sales Share by Application (2012-2017)
Figure United States Hospital Sales Growth (2012-2017)
Figure United States Clinic Sales Growth (2012-2017)
Figure United States Others Sales Growth (2012-2017)
Figure California Urokinase Revenue and Growth (2012-2017)
Figure California Urokinase Sales and Growth (2012-2017)
Table California Urokinase Sales by Type (2012-2017)
Table California Urokinase Sales Market Share by Type (2012-2017)
Table California Urokinase Sales by Application (2012-2017)
Table California Urokinase Sales Market Share by Application (2012-2017)
Figure New York Urokinase Revenue and Growth (2012-2017)
Figure New York Urokinase Sales and Growth (2012-2017)
Table New York Urokinase Sales by Type (2012-2017)
Table New York Urokinase Sales Market Share by Type (2012-2017)
Table New York Urokinase Sales by Application (2012-2017)
Table New York Urokinase Sales Market Share by Application (2012-2017)
Figure Texas Urokinase Revenue and Growth (2012-2017)
Figure Texas Urokinase Sales and Growth (2012-2017)
Table Texas Urokinase Sales by Type (2012-2017)
Table Texas Urokinase Sales Market Share by Type (2012-2017)
Table Texas Urokinase Sales by Application (2012-2017)
Table Texas Urokinase Sales Market Share by Application (2012-2017)
Figure Florida Urokinase Revenue and Growth (2012-2017)
Figure Florida Urokinase Sales and Growth (2012-2017)
Table Florida Urokinase Sales by Type (2012-2017)
Table Florida Urokinase Sales Market Share by Type (2012-2017)
Table Florida Urokinase Sales by Application (2012-2017)
Table Florida Urokinase Sales Market Share by Application (2012-2017)
Figure Illinois Urokinase Revenue and Growth (2012-2017)
Figure Illinois Urokinase Sales and Growth (2012-2017)
Table Illinois Urokinase Sales by Type (2012-2017)
Table Illinois Urokinase Sales Market Share by Type (2012-2017)
Table Illinois Urokinase Sales by Application (2012-2017)
Table Illinois Urokinase Sales Market Share by Application (2012-2017)
Figure United States Urokinase Sales, Revenue and Growth Rate (2017-2022)
Table United States Urokinase Sales Forecast by States (2017-2022)
Table United States Urokinase Market Share Forecast by States (2017-2022)
Table United States Urokinase Sales Forecast by Type (2017-2022)
Table United States Urokinase Market Share Forecast by Type (2017-2022)
Table United States Urokinase Sales Forecast by Application (2017-2022)
Table United States Urokinase Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Urokinase
Figure Manufacturing Process Analysis of Urokinase
Figure Urokinase Industrial Chain Analysis
Table Raw Materials Sources of Urokinase Major Manufacturers in 2016
Table Major Buyers of Urokinase
Table Distributors/Traders/ Dealers List